More research is needed to address barriers to therapeutic monitoring of prostate cancer patients on androgen deprivation ...

Local radiation therapy appears beneficial for men with bone metastatic hormone-sensitive prostate cancer (mHSPC).

Investigators studied cardiotoxicities of first-line regimens for metastatic hormone-sensitive and nonmetastatic castration-resistant prostate cancer.

Hot flushes in men are sudden, intense heat waves caused by hormone therapy. Learn how to manage them effectively.

Discover new insights into testosterone recovery following androgen deprivation therapy in men undergoing radiotherapy for ...

Androgen deprivation therapy remains fundamental, but resistance necessitates additional treatments like androgen receptor signaling inhibitors. Chemotherapy, especially docetaxel, is combined with ...

The rate at which PSA rises after hormonal therapy for prostate cancer is a key factor in determining the effectiveness of ...

"Artera secures California licence for AI-based prostate test" was originally created and published by Medical Device Network ...

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced ...

Androgen deprivation is the mainstay of therapy of advanced prostate cancer treatment, but the cure rate is low and patients eventually become castrate resistant. Castration-resistant prostate ...

Bayer said on Monday that it has applied to the EU's drugs regulator for the use of Nubeqa, also known as darolutamide, in combination with androgen deprivation therapy. The U.S. Food and Drug ...